SIRT1 and chronic myelogenous leukemia, BCR-ABL1 positive: Although tenovin-6 (TV-6), a small molecule SIRT1 inhibitor, sensitizes mice and human CML progenitor cells to imatinib-induced apoptosis, there was no increase in survival with TV-6 combined with imatinib compared with single drug treatment.